UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to treat ...

A new analysis shows no clear link between paternal valproate use and harm in offspring, raising questions about the EMA ...

Spread mainly by fruit bats, Nipah virus is fatal in up to 85% of cases. Symptoms include fever, headaches, pain, vomiting ...

Following global reports of serious adverse events in older people, the government’s independent expert advisory body, the UK ...

Pharmacovigilance Risk Assessment Committee (PRAC) has concluded its review of semaglutide-containing medicines, confirming a ...

Couple campaigning for the Government to sanction pay for a new drug called givinostat, which slows down muscle-wasting ...

Amvuttra is the first and only RNA interference (RNAi) therapeutic approved by the EC for both the cardiomyopathy and the ...

Archie Ennis suffers from Duchenne muscular dystrophy and is in desperate need of medication to help his condition ...

A "sub-study" of a late-stage clinical trial found the drug, obicetrapib, significantly reduced levels of a certain type of ...

Privately-held Italian pharma company Italfarmaco today revealed that the European Commission (EC) has granted conditional ...

A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

Beacon Therapeutics recently announced positive six-month interim safety and efficacy results from the Phase 2 DAWN trial of ...